title: Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity.
abstract: Progressive multifocal leukoencephalopathy (PML) is an often fatal demyelinating disease caused by lytic infection of oligodendrocytes with JC virus (JCV). The development of PML in non-immunosuppressed individuals is a growing concern with reports of mortality in patients treated with mAb therapies. JCV can persist in the kidneys, lymphoid tissue and bone marrow. JCV gene expression is restricted by non-coding viral regulatory region sequence variation and cellular transcription factors. Because JCV latency has been associated with cells undergoing haematopoietic development, transcription factors previously reported as lymphoid specific may regulate JCV gene expression. This study demonstrates that one such transcription factor, Spi-B, binds to sequences present in the JCV promoter/enhancer and may affect early virus gene expression in cells obtained from human brain tissue. We identified four potential Spi-B-binding sites present in the promoter/enhancer elements of JCV sequences from PML variants and the non-pathogenic archetype. Spi-B sites present in the promoter/enhancers of PML variants alone bound protein expressed in JCV susceptible brain and lymphoid-derived cell lines by electromobility shift assays. Expression of exogenous Spi-B in semi- and non-permissive cells increased early viral gene expression. Strikingly, mutation of the Spi-B core in a binding site unique to the Mad-4 variant was sufficient to abrogate viral activity in progenitor-derived astrocytes. These results suggest that Spi-B could regulate JCV gene expression in susceptible cells, and may play an important role in JCV activity in the immune and nervous systems.
authors.affiliation: Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1296, USA.
authors.forename: Leslie J
authors.initials: LJ
authors.lastname: Marshall
authors.forename: Lisa
authors.initials: L
authors.lastname: Dunham
authors.forename: Eugene O
authors.initials: EO
authors.lastname: Major
mesh_terms: D001921:Brain / Q000821:virology; D002460:Cell Line; D004268:DNA-Binding Proteins / Q000378:metabolism*; D024202:Electrophoretic Mobility Shift Assay; D015870:Gene Expression; D006801:Humans; D007577:JC Virus / Q000472:pathogenicity*; D008214:Lymphocytes / Q000821:virology; D009836:Oligodendroglia / Q000821:virology; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D020080:Tandem Repeat Sequences; D014157:Transcription Factors / Q000378:metabolism*; D014775:Virus Activation
chemical_list: D004268:DNA-Binding Proteins; D014157:Transcription Factors; C076877:SPIB protein, human
references.citation: Blood. 2008 Sep 1;112(5):1804-12
references.pmid: 18552212
references.citation: J Virol. 1984 Aug;51(2):458-69
references.pmid: 6086957
references.citation: J Virol. 1987 May;61(5):1435-41
references.pmid: 3033272
references.citation: Eur J Biochem. 1993 Jan 15;211(1-2):7-18
references.pmid: 8425553
references.citation: J Virol. 2001 Oct;75(20):9687-95
references.pmid: 11559801
references.citation: J Virol. 2010 Oct;84(20):10448-56
references.pmid: 20686041
references.citation: J Immunol. 2004 Jan 1;172(1):144-54
references.pmid: 14688320
references.citation: Virus Res. 1987 Apr;7(2):159-68
references.pmid: 3035817
references.citation: EMBO J. 1987 May;6(5):1323-30
references.pmid: 3038516
references.citation: Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1087-91
references.pmid: 7862639
references.citation: J Neurovirol. 2000 Oct;6(5):398-409
references.pmid: 11031693
references.citation: Microbiol Immunol. 2007;51(3):339-47
references.pmid: 17380054
references.citation: J Virol. 1985 Jan;53(1):306-11
references.pmid: 2981353
references.citation: Blood. 1995 May 15;85(10):2918-28
references.pmid: 7742552
references.citation: EMBO J. 2002 May 1;21(9):2220-30
references.pmid: 11980719
references.citation: Proc Natl Acad Sci U S A. 1993 May 15;90(10):4743-7
references.pmid: 8389455
references.citation: J Infect Dis. 2002 Dec 1;186 Suppl 2:S180-6
references.pmid: 12424695
references.citation: Cell Growth Differ. 2002 Feb;13(2):69-75
references.pmid: 11864910
references.citation: Oncogene. 2003 Feb 20;22(7):964-73
references.pmid: 12592383
references.citation: Mol Cell Biol. 1993 Feb;13(2):961-9
references.pmid: 8423815
references.citation: Genes Dev. 1987 Nov;1(9):962-72
references.pmid: 2828177
references.citation: Ann Neurol. 2003 May;53(5):636-46
references.pmid: 12730998
references.citation: Genes Dev. 1987 Mar;1(1):65-74
references.pmid: 2828161
references.citation: J Virol. 1990 Dec;64(12):5812-22
references.pmid: 2173768
references.citation: Biochem Biophys Res Commun. 1988 Dec 15;157(2):419-25
references.pmid: 2849429
references.citation: EMBO J. 1997 Dec 1;16(23):7118-29
references.pmid: 9384589
references.citation: Oncogene. 1996 Feb 15;12(4):863-73
references.pmid: 8632909
references.citation: Oncogene. 2003 May 15;22(19):2882-96
references.pmid: 12771939
references.citation: Gene. 2005 Jun 20;353(1):134-46
references.pmid: 15936902
references.citation: J Leukoc Biol. 1999 Apr;65(4):428-38
references.pmid: 10204570
references.citation: Genes Dev. 1997 Jun 15;11(12):1605-17
references.pmid: 9203586
references.citation: J Virol. 1986 Dec;60(3):935-42
references.pmid: 3023682
references.citation: J Biol Chem. 1996 Feb 16;271(7):3385-91
references.pmid: 8631937
references.citation: Prog Clin Biol Res. 1983;105:41-59
references.pmid: 6304771
references.citation: Genes Dev. 1996 Jun 1;10(11):1369-81
references.pmid: 8647434
references.citation: J Neurochem. 1996 Aug;67(2):473-81
references.pmid: 8764570
references.citation: J Gen Virol. 1994 Jun;75 ( Pt 6):1281-90
references.pmid: 8207394
references.citation: J Virol. 1990 Jun;64(6):3139-43
references.pmid: 2159570
references.citation: J Neuroimmunol. 2008 Feb;194(1-2):153-64
references.pmid: 18178259
references.citation: EMBO J. 1987 Apr;6(4):1017-25
references.pmid: 3036487
references.citation: J Virol. 2003 May;77(9):5241-52
references.pmid: 12692226
references.citation: Nucleic Acids Res. 1991 May 11;19(9):2499
references.pmid: 2041787
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11665-70
references.pmid: 16861304
references.citation: J Virol. 1995 Sep;69(9):5843-8
references.pmid: 7637031
references.citation: J Exp Med. 1996 Jul 1;184(1):203-14
references.pmid: 8691135
references.citation: J Virol. 1986 Apr;58(1):216-9
references.pmid: 3005651
references.citation: Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5062-5
references.pmid: 8389465
references.citation: N Engl J Med. 1988 Feb 4;318(5):301-5
references.pmid: 2827029
references.citation: J Neurovirol. 1996 Apr;2(2):87-100
references.pmid: 8799200
references.citation: J Virol. 1994 Nov;68(11):6947-58
references.pmid: 7933076
references.citation: Oncogene. 1995 Oct 19;11(8):1549-60
references.pmid: 7478579
references.citation: Genes Dev. 1991 Nov;5(11):1935-45
references.pmid: 1657708
references.citation: J Virol. 1986 May;58(2):651-4
references.pmid: 3009875
references.citation: J Virol. 1993 Jan;67(1):572-6
references.pmid: 8380093
references.citation: J Gen Virol. 1993 Aug;74 ( Pt 8):1499-507
references.pmid: 8393910
references.citation: Mol Cell Biol. 1992 Oct;12(10):4297-304
references.pmid: 1406622
references.citation: J Biol Chem. 1999 Nov 26;274(48):34245-52
references.pmid: 10567398
references.citation: Mol Cell Biol. 1988 Oct;8(10):3975-87
references.pmid: 3141781
references.citation: J Virol. 1990 Apr;64(4):1657-66
references.pmid: 2319649
references.citation: J Biol Chem. 1989 Apr 25;264(12):7025-32
references.pmid: 2540170
references.citation: J Infect Dis. 2009 Mar 15;199(6):881-8
references.pmid: 19434914
references.citation: J Gen Virol. 2008 Jun;89(Pt 6):1396-1401
references.pmid: 18474555
references.citation: J Neurovirol. 2008 Oct;14(5):455-8
references.pmid: 18989816
references.citation: J Virol. 1995 Apr;69(4):2434-42
references.pmid: 7884891
references.citation: Lupus. 1997;6(3):325-6
references.pmid: 9296778
references.citation: Cell. 1988 Jun 3;53(5):723-30
references.pmid: 2836066
references.citation: J Biol Chem. 1992 Jul 15;267(20):14204-11
references.pmid: 1321139
references.citation: Annu Rev Med. 2010;61:35-47
references.pmid: 19719397
references.citation: J Biol Chem. 1999 Apr 16;274(16):11115-24
references.pmid: 10196196
references.citation: N Engl J Med. 2009 Sep 10;361(11):1041-3
references.pmid: 19741226
references.citation: J Neuroimmune Pharmacol. 2010 Sep;5(3):404-17
references.pmid: 20401541
references.citation: J Virol. 1994 Nov;68(11):7637-43
references.pmid: 7933155
references.citation: Exp Neurol. 2000 Feb;161(2):585-96
references.pmid: 10686078
references.citation: Virology. 1996 Feb 1;216(1):90-101
references.pmid: 8615010
references.citation: Virology. 1993 May;194(1):97-109
references.pmid: 8386892
references.citation: J Virol. 1996 Jun;70(6):4150-6
references.pmid: 8648759
references.citation: Nature. 1995 Jun 29;375(6534):812-5
references.pmid: 7596417
references.citation: Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1580-4
references.pmid: 8434021
references.citation: Immunity. 1999 Apr;10(4):399-408
references.pmid: 10229183
references.citation: J Virol. 2000 Jun;74(11):5151-60
references.pmid: 10799590
references.citation: Virology. 1989 Jun;170(2):353-61
references.pmid: 2543122